# Efficacy and Safety of Pediatric Drugs in Nasal Congestion

> **NCT02601235** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 292 (actual)

## Conditions studied

- Nasal Congestion

## Interventions

- **DRUG:** Naridrin
- **DRUG:** Afrin

## Key facts

- **NCT ID:** NCT02601235
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2018-08-03
- **Final completion:** 2019-04-03
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601235, "Efficacy and Safety of Pediatric Drugs in Nasal Congestion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02601235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*